Evidence map›Paper›PMID 27195758›Full record

ReviewVaccine2016

Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.

Edwin J Asturias, Melinda Wharton, Robert Pless, Noni E MacDonald, Robert T Chen, Nicholas Andrews, David Salisbury, Alexander N Dodoo, Kenneth Hartigan-Go, Patrick L F Zuber

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Vaccine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Vaccine safety: An evolving evidence-based science.British journal of clinical pharmacology · 2019
    Article
  9. [An investigation of vaccination in children with human immunodeficiency virus infection].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2019
    Article
  10. Review
  11. Overcoming barriers in HPV vaccination and screening programs.Papillomavirus research (Amsterdam, Netherlands) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Edwin J AsturiasCenter for Global Health, Colorado School of Public Health, Aurora, CO, USA; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: edwin.asturias@ucdenver.edu.
Melinda WhartonNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Robert PlessCommunicable Disease Surveillance, Public Health Agency of Canada, Canada.
Noni E MacDonaldDepartment of Pediatrics, Dalhousie University, Halifax, NS, Canada.
Robert T ChenNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Nicholas AndrewsStatistics, Modelling and Economics Department, Public Health England, London, UK.
David SalisburyCentre for Global Health Security, Chatham House, London, UK.
Alexander N DodooWHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana Medical School, Ghana.
Kenneth Hartigan-GoCenter for Development Management, Asian Institute of Management, Philippines.
Patrick L F ZuberDepartment of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

In 1999, the Global Advisory Committee on Vaccine Safety (GACVS) was established by the World Health Organization (WHO) to provide independent scientific advice on issues relating to the safety of vaccines and immunization. Fifteen years onward, we conducted a multi-faceted review to evaluate the impact, reach and challenges facing GACVS, including the role GACVS plays in informing global, regional and WHO member state vaccine policy. The methods included measures of organizational structure, citation impact, themes approached, and a discussion by previous and current members to evaluate past, present and future challenges. Given the increasing range of data sources and the deployment of many new vaccines, the Committee is facing the complex task of identifying the best available evidence for recommendations on vaccine safety. To help meet the increased demand for public transparency in decision making, GACVS-structured methodology for evidence-based decisions is evolving. GACVS also promotes best practices and capacity building for timely and accurate risk assessment; risk communications; outreach to help countries maintain and, if needed, rebuild public trust in vaccines; and advocacy for bridging the major gaps in vaccine safety capacity globally.

Indexed as

Consumer Product SafetyAdvisory CommitteesHealth PolicyHumansVaccinesWorld Health OrganizationVaccinesGlobal Advisory Committee on Vaccine SafetyGlobal public healthImmunization programVaccine adverse eventsVaccine policyVaccine safety

Identifiers

PMID27195758
PMCPMC5085263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.